Spectinomycin
From Wikipedia, the free encyclopedia
|
Spectinomycin
|
|
| Systematic (IUPAC) name | |
| (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)- 4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino) decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C14H24N2O7 |
| Mol. mass | 332.35 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
B(US) |
| Legal status |
not available in US |
| Routes | ? |
Spectinomycin (marketed as the hydrochloride salt spectinomycin hydrochloride under the trade name Trobicin) is an aminocyclitol antibiotic produced by the bacterium Streptomyces spectabilis.
[edit] Mechanism
It binds to the 30S ribosomal subunit in invading bacteria and interrupts protein synthesis.
[edit] Uses
It is given by injection to treat gonorrhea, especially in patients who are allergic to penicillins.
[edit] Side effects
Side effects include itching, chills, stomach-ash, and red rash.
|
||||||||
|
||||||||||||||||||||

